BUNIA, Democratic Republic of the Congo — Health authorities in the Democratic Republic of the Congo (DRC) officially began vaccinating front-line health care workers on Saturday in Bunia, the epicenter of the fastest-growing and deadliest Ebola outbreak in the nation’s history.
Government figures released Saturday show the country has recorded 7,541 confirmed cases and 3,639 deaths. The outbreak, heavily concentrated in Ituri province, has surpassed all 17 previous Ebola outbreaks in the DRC and continues to spread rapidly under volatile regional conditions.
Protecting Front-Line Workers on the Ground
Front-line medical staff are receiving priority access to the Ervebo vaccine. While Ervebo is officially licensed for the more common Zaire ebolavirus strain, health officials hope it will offer critical risk reduction for health workers facing daily exposure in high-transmission zones like Bunia and Mongbwalu.
Nikole Landu, a local healthcare worker who stepped forward for her shot on Saturday, emphasized the high personal risks medical staff take each day.
“I wanted to get vaccinated because I am in constant contact with sick people and at high risk of catching this disease,” Landu said. “So the vaccine I received today will help protect me. I might still get the disease, but I’m less likely to develop a severe case.”
The military governor of Ituri, Maj. Gen. Gaby Kasongo Mulumba, was among those vaccinated on Saturday in Bunia.
“The launch of this vaccination drive for front-line staff in Ituri is not an arbitrary choice, as these workers are particularly exposed and deeply involved in the response,” Mulumba said. “Together, we can defeat Bundibugyo virus disease and protect our community.”
The Challenge: A Rare Virus Strain and Complex Crisis
Public health officials face a dual challenge: controlling a rare strain of the virus while navigating severe logistical and operational obstacles on the ground.
- The Bundibugyo Strain: Unlike past outbreaks caused by the Zaire virus, the current surge is caused by the Bundibugyo ebolavirus—a strain with no licensed vaccine or specific antiviral treatment.
- Compassionate-Use Program: Because Ervebo and Bundibugyo are related species within the Ebolavirus genus, authorities are deploying 70,000 WHO-approved doses under a compassionate-use protocol. About 50,000 doses are going directly to front-line workers, while 20,000 doses are assigned to a clinical trial evaluating cross-protection efficacy.
- Compound Operational Hurdles: Transmission is accelerating amid ongoing armed conflict, massive civilian displacement, an active health workers’ strike, and rapid population movements across regional borders.
The World Health Organization (WHO) warned that the epidemic remains out of control and is on track to rival or surpass the 2014–2016 West Africa Ebola outbreak, which killed more than 11,000 people across Guinea, Liberia, and Sierra Leone.
The Bunia rollout follows initial deployments last month in Kisangani (Tshopo province), with plans expanding across 14 health zones in Tshopo, Bas-Uele, and Haut-Uele provinces.
